Skip to main content

Aramark

For the period ended Dec 29, 2023. Filed Feb 6, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 29, 2023 · Filed Feb 6, 2024

ARMK$54.22-0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

Three Months Ended
December 29, 2023December 30, 2022
Cash flows from operating activities of Continuing Operations:
Net income from Continuing Operations$28,517$37,998
Adjustments to reconcile Net income from Continuing Operations to Net cash used in operating activities of Continuing Operations
Depreciation and amortization105,544102,597
Asset write-downs—18,316
Reduction of contingent consideration liability (see Note 13)—(29,941)
Deferred income taxes1,17512,806
Share-based compensation expense13,65420,574
Changes in operating assets and liabilities:
Receivables(209,339)(100,528)
Inventories33,3036,868
Prepayments and Other Current Assets(7,864)4,549
Accounts Payable(180,799)(254,225)
Accrued Expenses(460,413)(415,251)
Payments made to clients on contracts(45,075)(33,868)
Other operating activities64,22014,357
Net cash used in operating activities of Continuing Operations(657,077)(615,748)
Cash flows from investing activities of Continuing Operations:
Purchases of property and equipment and other(115,621)(88,904)
Disposals of property and equipment4,4203,347
Acquisition of certain businesses, net of cash acquired(83,316)(3,505)
Other investing activities(3,451)17,874
Net cash used in investing activities of Continuing Operations(197,968)(71,188)
Cash flows from financing activities of Continuing Operations:
Proceeds from long-term borrowings228,221301,790
Payments of long-term borrowings(1,538,997)(19,415)
Net change in funding under the Receivables Facility600,000395,065
Payments of dividends(24,915)(28,566)
Proceeds from issuance of common stock4,49628,198
Other financing activities(47,808)(14,538)
Net cash (used in) provided by financing activities of Continuing Operations(779,003)662,534
Discontinued Operations:
Net cash provided by operating activities—8,543
Net cash used in investing activities—(12,936)
Net cash used in financing activities—(5,476)
Net cash used in Discontinued Operations—(9,869)
Effect of foreign exchange rates on cash and cash equivalents and restricted cash5,33411,661
Decrease in cash and cash equivalents and restricted cash(1,628,714)(22,610)
Cash and cash equivalents and restricted cash, beginning of period1,972,367365,431
Cash and cash equivalents and restricted cash, end of period$343,653$342,821
Supplemental disclosure of cash flow informationThree Months Ended
(in millions)December 29, 2023December 30, 2022
Interest paid$111.5$113.5
Income taxes paid45.412.0

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated Balance Sheets:

Balance Sheet classificationThree Months Ended
(in thousands)December 29, 2023December 30, 2022
Cash and cash equivalents$295,597$288,228
Restricted cash in Prepayments and other current assets48,05637,771
Cash and cash equivalents in Current assets of discontinued operations—16,822
Total cash and cash equivalents and restricted cash$343,653$342,821
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.